A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

NCT00301301 · clinicaltrials.gov ↗

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkins Lymphoma

Interventions

DRUG: Gemcitabine
DRUG: Cisplatinum
DRUG: Rituximab

Sponsor

Royal Marsden NHS Foundation Trust